Bacterial and fungal co-infection in individuals with COVID-19 (search done on 18 April 2020)

Added June 26, 2020

Citation: Rawson TM, Moore LS, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases. 2020 May 2.

What is this? Identifying bacterial and fungal co-infection of COVID-19 patients would provide useful information for policy makers and healthcare providers.

In this rapid review, the authors searched for articles reporting clinical data for patients with coronavirus infection and bacterial or fungal co-infection in hospital settings. They restricted their searches to articles published in English, Mandarin and Italian between 1 January 2000 and 18 April 2020. They included 9 studies that reported on bacterial/fungal coinfection in patients with COVID-19, as well as studies of SARS (5 studies), MERS (1) and other coronaviruses (3). 

What was found: At the time of this review, the included studies showed that 8% of COVID-19 patients reported bacterial or fungal co-infection during hospital admission and 72% of COVID-19 cases received antibacterial therapy.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.